Lombard Odier Asset Management (Europe)’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $9.5M | Buy |
151,463
+8,184
| +6% | +$655K | 0.52% | 73 |
|
|
2025
Q4 | $13.7M | Buy |
+143,279
| New | +$14M | 0.69% | 54 |
|
|
2025
Q3 | – | Sell |
-89,290
| Closed | -$9.59M | – | 138 |
|
|
2025
Q2 | $9.59M | Buy |
89,290
+63,655
| +248% | +$6.44M | 0.69% | 50 |
|
|
2025
Q1 | $2.59M | Buy |
+25,635
| New | +$2.58M | 0.21% | 113 |
|
|
2021
Q1 | – | Sell |
-19,680
| Closed | -$703K | – | 260 |
|
|
2020
Q4 | $703K | Buy |
19,680
+7,195
| +58% | +$259K | 0.04% | 160 |
|
|
2020
Q3 | $477K | Hold |
12,485
| – | – | 0.03% | 187 |
|
|
2020
Q2 | $438K | Hold |
12,485
| – | – | 0.07% | 114 |
|
|
2020
Q1 | $407K | Sell |
12,485
-2,420
| -16% | -$94.5K | 0.03% | 179 |
|
|
2019
Q4 | $674K | Hold |
14,905
| – | – | 0.05% | 159 |
|
|
2019
Q3 | $606K | Hold |
14,905
| – | – | 0.05% | 162 |
|
|
2019
Q2 | $641K | Hold |
14,905
| – | – | 0.06% | 159 |
|
|
2019
Q1 | $572K | Hold |
14,905
| – | – | 0.06% | 155 |
|
|
2018
Q4 | $527K | Buy |
14,905
+1,295
| +10% | +$47K | 0.05% | 164 |
|
|
2018
Q3 | $524K | Hold |
13,610
| – | – | 0.04% | 199 |
|
|
2018
Q2 | $445K | Hold |
13,610
| – | – | 0.04% | 206 |
|
|
2018
Q1 | $372K | Sell |
13,610
-2,505
| -16% | -$68.1K | 0.03% | 239 |
|
|
2017
Q4 | $399K | Sell |
16,115
-2,144
| -12% | -$59.1K | 0.03% | 244 |
|
|
2017
Q3 | $533K | Hold |
18,259
| – | – | 0.04% | 214 |
|
|
2017
Q2 | $506K | Hold |
18,259
| – | – | 0.03% | 215 |
|
|
2017
Q1 | $454K | Sell |
18,259
-2,676
| -13% | -$65.1K | 0.03% | 206 |
|
|
2016
Q4 | $453K | Hold |
20,935
| – | – | 0.16% | 165 |
|
|
2016
Q3 | $498K | Hold |
20,935
| – | – | 0.17% | 159 |
|
|
2016
Q2 | $489K | Buy |
+20,935
| New | +$453K | 0.03% | 193 |
|
Other funds holding BSX
VCM
VPM